Page 9 - Manufacturing Practice News Today

SEED Innovations Ltd (AIM:SEED, OTC:FFRIF) said its investee company Little Green Pharma (LGP) has won an Italian government tender to deliver a shipment of...

The tender award gives LPG access to the Italian market with a 60mln population and a total addressable market worth A$10bn

Investigational New Drug (IND)-enabling studies for the myotonic dystrophy type 1 (DM1) program development candidate continue as planned; invited to...

11.02.2022 - Investigational New Drug (IND)-enabling studies for the myotonic dystrophy type 1 (DM1) program development candidate continue as planned; invited to present new rodent pharmacokinetic (PK) and bioavailability data in an oral presentation at an ... Seite 1

/PRNewswire/ -- Nanoform, an innovative nanoparticle medicine enabling company, today announced it has signed a GMP1 manufacturing program (clinical...

/PRNewswire/ -- Nanoform, an innovative nanoparticle medicine enabling company, today announced it has signed a GMP1 manufacturing program (clinical...

FARMINGDALE, NY (PRWEB) January 31, 2022 -- NutraScience Labs, a leading provider of dietary supplement manufacturing services, today announced the opening of

This is the Hub for all the Veterinary Medicines Directorates communications on current and future regulatory changes.

Insider information Nanoform Finland Plc January 3, 2022 08:10 a.m. Finnish time / 07:10 a.m. Swedish time Nanoform sets two new near-term business targets for 2022 Helsinki, Finland - Nanoform,... | January 3, 2022

Eskayef Pharmaceuticals yesterday rolled out the world’s first generic version of Pfizer’s Covid pill Paxlovid, offering a highly effective defence against severe illness from the coronavirus in Bangladesh, where the majority of the population remain unvaccinated.